Home » Phase IIb Pancreatic Cancer Trial Commences for pSivida Product
Phase IIb Pancreatic Cancer Trial Commences for pSivida Product
A potential new brachytherapy treatment for inoperable pancreatic cancer is being studied in pSivida’s newly initiated Phase IIb clinical trial.
BrachySil is a combination of BioSilicon, a proprietary porous silicon, and the isotope phosphorus, a proven anti-cancer therapeutic. It can be delivered by endoscopic ultrasound, the company said.
The study will determine the safety of escalating radiation doses of the product.
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May